Retatrutide appears to have a similar safety profile to other GLP-1 medications: No increased risk of pancreatitis in trials so far No hepatotoxicity signals (liver damage) No cases of ketoacidosis Serious adverse events were rare (2.5% of participants) The trials are ongoing, so we'll learn more about long-term safety
Lyophilized GLP-RT is typically stored at approximately 4 F (20 C), protected from light and moisture
As you progress, monthly medical updates might prompt dosage adjustments
Hers used to offer compounded GLP-1 medications, but recently, they have discontinued them and only sell the name brands, created by Eli Lilly and Novo Nordisk (for now)
Patients benefit from a fully integrated care journey: pre-visit screening, structured consultations, regular follow-up visits with integrated monitoring, standardized documentation, and evidence-based treatment algorithms with built-in safety protocols